| For: | Nan YY, Zhang WJ, Huang DH, Li QY, Shi Y, Yang T, Liang XP, Xiao CY, Guo BL, Xiang Y. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma. World J Clin Cases 2021; 9(18): 4585-4598 [PMID: 34222425 DOI: 10.12998/wjcc.v9.i18.4585] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i18/4585.htm |
| Number | Citing Articles |
| 1 |
Shanhong Fang, Songye Wu, Peng Chen. Alpha-2-macroglobulin mitigates glucocorticoid-induced osteonecrosis via Keap1/Nrf2 pathway activation. Free Radical Biology and Medicine 2024; 225 doi: 10.1016/j.freeradbiomed.2024.09.048
|
| 2 |
Abigail Fleischli, Jonathan Bar, Meredith Manson, Brandon D. Ng, Shannon Meledathu, Amelia Burnett, Gabriella Chefitz, Yeriel D. Estrada, Digpal Gour, Ahuva Cices, Joel Correa da Rosa, Patrick M. Brunner, Emma Guttman-Yassky. Tape-strip transcriptomics identify immune signatures in cutaneous T-cell lymphoma distinct from benign inflammatory skin diseases. Journal of Allergy and Clinical Immunology 2026; doi: 10.1016/j.jaci.2026.07.019
|
| 3 |
JunXiu Liu, JiaQi Qin, XiaoJing Shi, Qing Liu, XiaoCheng Cheng, Yue Zhou. MMP9 Serves as a Prognostic Biomarker and Immune‐Associated Regulator in Diffuse Large B‐Cell Lymphoma. Cell Biochemistry and Function 2026; 44(4) doi: 10.1002/cbf.70200
|
| 4 |
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Mamdouh Skafi, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Maria Eugenia Alvaro, Fortunato Morabito, Massimo Gentile. Minimal residual disease in diffuse large B‐cell lymphoma after first‐line therapy: Defining the continuum from metabolic remission to molecular clearance. British Journal of Haematology 2026; 209(2) doi: 10.1111/bjh.70619
|
| 5 |
Liyuan Dai, Ning Lou, Liling Huang, Lin Li, Le Tang, Yuankai Shi, Xiaohong Han. Spatial transcriptomics reveals prognostically LYZ+ fibroblasts and colocalization with FN1+ macrophages in diffuse large B-cell lymphoma. Cancer Immunology, Immunotherapy 2025; 74(4) doi: 10.1007/s00262-025-03968-7
|